Top Companies in the Catheters

The catheters market is projected to reach USD 45.99 billion by 2030, growing from USD 30.53 billion in 2025, registering a CAGR of 8.5% during the forecast period. A key factor driving the growth of the catheters market is the increasing global burden of chronic diseases, such as cardiovascular disorders, urinary tract infections, and neurovascular conditions—particularly among the elderly population. As aging individuals require long-term or recurring medical interventions, the demand for various types of catheters for diagnostic, surgical, and therapeutic procedures continues to rise.

The growing volume of minimally invasive surgeries and the rising preference for image-guided and catheter-based interventions are accelerating the adoption of catheters across clinical settings. Technological advancements, such as antimicrobial coatings, hydrophilic surfaces, and pressure-sensing smart catheters, enhance patient safety and procedural efficiency. These innovations significantly improve patient outcomes while reducing the risks associated with catheter-associated infections and complications.

To know about the assumptions considered for the study download the pdf brochure

Healthcare systems worldwide are witnessing a shift toward outpatient and home-based care, which is expanding the use of indwelling and intermittent catheters in ambulatory and long-term care settings. Furthermore, hospitals and clinics are increasingly investing in advanced catheter technologies to streamline workflow, lower procedural costs, and improve care delivery. In response, leading market players are expanding their portfolios through product innovation, strategic acquisitions, and regional expansion to meet the evolving demands of both providers and patients.

Prominent companies operating in the catheters market include Boston Scientific Corporation (US), Medtronic PLC (Ireland), B. Braun SE (Germany), Becton Dickinson and Company (US), Stryker Corporation (US), Abbott Laboratories (US), Terumo Corporation (Japan), Coloplast A/S (Denmark), Convatec Group PLC (UK), Merit Medical Systems (US), Johnson & Johnson Services, Inc., (US), Cook (US), Edwards Lifesciences Corporation (US), Nipto Corporation (Japan), Teleflex Incorporated (US), Cardinal Health (US), Hollister Incorporated (US), Integra LifeSciences Corporation (US), Koninklijke Philips N.V. (Netherlands), and MicroPort Scientific Corporation (China). These players leverage technological innovation, partnerships, and targeted regional expansion to strengthen their position and tap into emerging opportunities across global markets.

• In October 2024, Boston Scientific Corporation received FDA approval for its FARAWAVE NAV Ablation Catheter, a navigation-enabled system designed for treating paroxysmal atrial fibrillation (AF). Additionally, the company secured FDA 510 (k) clearance for its new FARAVIEW Software, enhancing the catheter's integration and navigation capabilities during ablation procedures.
• In September 2024, Becton, Dickinson and Company acquired the Critical Care product group of Edwards Lifesciences for USD 4.2 billion. This strategic acquisition included Edwards’ advanced monitoring solutions and the Swan Ganz pulmonary artery catheters, aimed at strengthening BD’s portfolio of smart, connected care technologies in the catheter market.

Boston Scientific Corporation (US) is a global medical device company developing, manufacturing, and marketing interventional and diagnostic products, including balloon catheters, guide catheters, and drug-eluting stents. The company operates through three business divisions: Cardiovascular, MedSurg, and Neuromodulation. Its cardiovascular division covers interventional cardiology therapies and electrophysiology, offering catheters for urology, endoscopy, and peripheral interventions. With a strong international presence, Boston Scientific has key subsidiaries in Singapore, Belgium, Ireland, Costa Rica, the Netherlands, and Japan, supporting its widespread market reach and operational strength.

Medtronic PLC (Ireland) is a leading medical technology company that designs, manufactures, and markets a broad portfolio of devices for cardiac, neurological, vascular, and chronic conditions. It operates through four business divisions: Cardiovascular, Medical Surgical, Neuroscience, and Diabetes. The cardiovascular division of the company offers various catheter solutions and is subdivided into Cardiac Rhythm & Heart Failure, Structural Heart & Aortic, and Coronary & Peripheral Vascular. Medtronic has a global footprint with over 350 locations in more than 150 countries. Its notable subsidiaries include operations in Singapore, Japan, the Netherlands, India, and the US, reflecting its extensive global distribution and manufacturing network.

Market Ranking:

The catheters market is competitive, with the top five companies—Boston Scientific Corporation (US), Medtronic plc (Ireland), Becton Dickinson and Company (US), Johnson & Johnson Services, Inc. (US), and Teleflex Incorporated (US)—holding a significant share of the global market. Boston Scientific stands out with its broad catheter portfolio covering interventional cardiology, electrophysiology, and peripheral interventions, supported by worldwide distribution and innovation in minimally invasive solutions. Medtronic leverages its extensive cardiovascular and structural heart expertise to deliver a range of high-performance catheters for cardiac rhythm and vascular applications. Becton Dickinson strengthens its presence by integrating smart technologies and acquisition-led portfolio expansion, especially in critical care and urology catheter systems. Johnson & Johnson, through its subsidiary Biosense Webster, maintains a strong position in electrophysiology and ablation catheter systems, focusing on clinical precision and procedural efficiency. Teleflex offers a diverse catheter product line across vascular access, anesthesia, and urology, supported by deep hospital engagement and product reliability. While these players dominate the market, smaller and regional companies continue to innovate in design, coating materials, and infection prevention, contributing to a dynamic, competitive environment.

Related Reports:

Catheters Market by Type (Cardiovascular (Electrophysiology, Coronary Balloon, IVUS/OCT), Intravenous (CVC, PIVC, Midline), Urological, Neurovascular), Indication (Cardiac, Vascular, Kidney, Blood Transfusion, IV Medication Delivery and Fluid Management) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets Inc.
1615 South Congress Ave.
Suite 103,
Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com